Please login to the form below

Not currently logged in
Email:
Password:

Creabilis

This page shows the latest Creabilis news and features for those working in and with pharma, biotech and healthcare.

UK biotech gains further £47.2m from Biomedical Catalyst funding

UK biotech gains further £47.2m from Biomedical Catalyst funding

For example, clinical-stage biotech company Creabilis leveraged additional capital alongside its award to fund a large clinical trial in atopic dermatitis.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    175. Creabilis (UK). Sienna. Acquisition. Portfolio of first-in-class topical. 150. Global rights unless stated. ... Deal structure. Comments. Creabilis. Sienna Biopharmaceuticals. $150m. Undisclosed upfront payments. Regulatory and commercial milestone

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...

Infographics